Multimodal Nutritional and Sarcopenia Assessment for Risk Stratification in Lung Cancer Surgery
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This prospective observational cohort study aims to evaluate the prognostic value of multimodal nutritional status and sarcopenia assessment in patients undergoing lung cancer surgery. Postoperative complications, mortality, and prolonged hospital stay remain major clinical concerns in thoracic surgery. Although malnutrition and sarcopenia are recognized as important determinants of surgical outcomes, their combined and multidimensional evaluation has not been sufficiently studied. Adult patients undergoing anatomical lung resection for primary lung cancer will be included. Nutritional status will be assessed using serum biomarkers, inflammatory indices, and validated clinical nutritional scores. Sarcopenia will be evaluated using computed tomography-based muscle mass and density measurements, as well as ultrasonographic muscle thickness. These parameters will be analyzed in relation to postoperative complications, intensive care unit (ICU) requirement, length of hospital stay, and mortality. Multivariable analyses will be performed to identify independent predictors, and a combined risk stratification model will be developed. This study aims to improve preoperative risk assessment and to support personalized perioperative management strategies, including identification of patients who may benefit from targeted nutritional optimization and prehabilitation.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek 18 lat lub więcej
- •Pacjent przygotowywany do operacji usunięcia części lub całego płuca z powodu pierwotnego raka płuc
- •Dostępne badanie tomografii (CT) klatki piersiowej wykonane maksymalnie 30 dni przed operacją
- •Ukończona ocena stanu odżywienia i pomiary grubości mięśni wykonane przed operacją
- •Możliwość podpisania świadomej zgody na udział w badaniu
✗ Disqualifies
- •Pacjent otrzymał chemioterapię, immunoterapię lub radioterapię przed operacją
- •Operacja w trybie nagłym (zagrażająca życiu)
- •Planowana całkowita resekcja obu płuc
- •Jednoczesne usunięcie innego narządu podczas tej samej operacji
- •Niepełne lub niewyraźne wyniki badań obrazowych lub pomiarów
- •Pacjent przyjmuje leki osłabiające odporność lub ma raka z przerzutami
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- July 24, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (1)
Ondokuz Mayis University Faculty of Medicine, Department of Thoracic Surgery
Samsun, Turkey (Türkiye)
Trial contact
Caner İşevi, MD
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/26/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.